Scaling digital transformation in pharma and healthcare for enterprise value

Over the years, digital has quietly reshaped many parts of the industry. Teams have tested new tools, piloted smarter workflows and seen excellent results. But in pharma and healthcare, these successes have often stayed limited. While digital leaders have experimented with high-value digital products, they are still not scaling operational breakthroughs across different business processes.

Clinical trials still take longer than they should. Supply chain and manufacturing systems are under pressure as advanced therapies like CAR-T, messenger RNA (mRNA) and antibody-drug conjugates become more common, fundamentally changing how products are manufactured and delivered. Commercial teams are only just beginning to tap into the full value of the data they collect.

In healthcare, discussions on how to transform treatment experiences and deliver personalized care are underway.

The question now is: how do organizations take what works and scale it consistently across the enterprise? Likely, by creating a system where digital transformation in healthcare and pharma feels less like experimentation and more like a long-term commitment. 

Rethinking digital programs in pharma to create value

Digital is one area where even small improvements can help create bigger changes. Emerging technologies like generative artificial intelligence (AI) can prove to be a value multiplier. But the approach still requires understanding the core foundations of different digital programs. Organizations can scale these programs to create value:

Clinical development 

Today, only a limited number of trials are designed with speed and patient experience at the center. Recruitment as well remains a challenge, when trials are designed using better insights and supported by digital tools like remote monitoring and decentralized models, they become easier to run, and participants are more likely to enroll.

• Data optimized clinical trial design: Uses AI and analytics to optimize trail design and accelerate drug development.

• Digital health-enabled trial execution: Uses digital health tools, remote data and decentralized methods to run clinical trials, reduce trial time and cost and improve results.

Supply chain and manufacturing

Traditional systems aren’t always built for precision and variability. The opportunity lies in making better use of data to support nano and micro product launches and provide the right care to patients. Value lies in sing data proactively to increase revenue, minimize unplanned scrapping and maximize production schedules while keeping an eye on the inventory.

• AI-driven yield optimization: Optimize processes across the supply chain through AI and machine learning analysis.

• Data-driven scrap reduction: Important for reducing clinical trial waste.

• AI-optimized planning and scheduling: Improves overall run-rate and manufacturing capacity.

Commercial engagement

To create value, healthcare providers (HCPs) need to collaborate with pharma representatives to build more personalized and engaging experiences for their patients and customers. 

• Digital and field orchestration and precision engagement: Requires marketing teams to interact with HCPs and integrated delivery networks to improve customer experiences and product revenue.

• Hyper-personalized content marketing: Addresses HCPs and patients’ preferences and creates content that’s relevant to the audience. 

Commercial teams have more data than ever before. The challenge remains in using it well. Understanding what patients want in a specific moment and responding in ways that feel relevant through the lens of preventative care and wellness. This is where healthcare consulting solutions can make a difference. 

Rethinking digital transformation in healthcare to create value

Digital transformation in healthcare can help teams move beyond broad segmentation and build more personalized, consistent interactions over time. Leaders need to:

• Focus on member-centered care. Since the COVID-19 pandemic, health equity has decreased significantly, especially in underserved regions of the world. 

• Increasing awareness by integrating clinical, behavioral, mental and social well-being programs should be the next best action.

• Make healthcare more personalized and affordable to bridge care gaps. Health plans should focus on reducing the cost of care.

Organizations that commit to this shift, moving beyond isolated wins and embracing enterprise-wide transformation, are best positioned to create meaningful and lasting impact at scale. The path forward requires a willingness to adapt, iterate and invest in the foundations that make digital change sustainable.